Two people can use the same vial, the same dose, and the same schedule, yet get completely different outcomes
En los estudios AWARD, el tratamiento con dulaglutida a dosis de 1,50mg semanal se asoci a una perdida ponderal promedio entre 0,70-2,90kg (0,70-3,00%)24,43, la prdida de peso se mantuvo de forma consistente durante 104 semanas de seguimiento en el estudio AWARD-544
It is effective in the treatment of obesity in patients with and without DM
Exenatide Extended-Release (Bydureon BCise) Bydureon BCise received FDA approval on October 20, 2017 offering a once weekly exenatide formulation
Our blood vessel quality is a direct indicator of how healthy our heart and cardiovascular system is